Financial Information

This section of the Karyopharm Therapeutics InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing.

Please note: All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes. Karyopharm Therapeutics assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQKPTI

Beta	0.92
Shares Outstanding	73.6M
Average Volume (10 days)	2.4M
Qtrly Dividend (Ann. Yield)	-- (--)

Per Share Data

Earnings (TTM)	($2.90)
Sales (TTM)	$0.99
Book Value (MRQ)	$1.14
Cash Flow (TTM)	($2.43)
Cash (MRQ)	$3.58

Analyst Views

Current Mean Recommendation	Strong Buy

Strong Buy	6
Buy	1
Hold	1
Underperform	0
Sell	0

Recent Insider Transactions

Mansoor Raza Mirza Director	(5,000) Sell Dec 18, 2020
Mansoor Raza Mirza Director	(5,000) Sell Dec 7, 2020
Mansoor Raza Mirza Director	(5,000) Sell Dec 7, 2020
Mansoor Raza Mirza Director	(5,000) Sell Dec 7, 2020
Mansoor Raza Mirza Director	(5,000) Sell Dec 7, 2020

Recent SEC Filings

8-K Company Events	Jan 11, 2021
3 New Insider	Jan 5, 2021
3 New Insider	Jan 5, 2021
4 Insider Buy/Sell	Dec 22, 2020
8-K Company Events	Dec 18, 2020

Currency in USD.
Quote data delayed by at least 15 minutes.
Earnings and Analyst data provided by Zacks.
Insiders data provided by Morningstar.